Inhibitors of hepatitis C virus
Compounds of Formula I are disclosed As well as pharmaceutically acceptable salts thereof. Methods of using said compounds and pharmaceutical compositions containing said compounds are also disclosed.
1. A compound of Formula lVa:
or a pharmaceutically acceptable salt thereof.
2. A compound of claim 1 which is:
or a pharmaceutically acceptable salt thereof.
3. A compound of Formula lVc:
or a pharmaceutically acceptable salt thereof.
4. A compound of claim 3 which is:
or a pharmaceutically acceptable salt thereof.
5. A compound of Formula lVe:
or a pharmaceutically acceptable salt thereof.
6. A compound of claim 5 which is:
or a pharmaceutically acceptable salt thereof.
7. A compound of formula lVg:
or a pharmaceutically acceptable salt thereof.
8. A compound of claim 7 which is:
or a pharmaceutically acceptable salt thereof.
9. A compound which is:
10. A composition comprising the compound of claim 9 and a pharmaceutically acceptable carrier.
11. A compound which is:
12. A composition comprising the compound of claim 11 and a pharmaceutically acceptable carrier.
13. A compound which is:
14. A composition comprising the compound of claim 13 and a pharmaceutically acceptable carrier.
15. A compound which is:
16. A composition comprising the compound of claim 15 and a pharmaceutically acceptable carrier.